Cytori Therapeutics (CYTX) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Other income (expense), net: -696K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other income (expense), net: -696K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.74 million.
Q1 2018 operating cash burn was $4.1 million, compared to $4.8 million for Q1 2017.
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
